MiMedx Group, Inc. (NASDAQ: MDXG) announced today a ruling has been rendered from the Patent Trial and Appeal Board ("PTAB") ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE